Profile
Michael J.
Taylor worked as a Senior Director of Clinical Development Sciences at Protein Design Labs, Inc. from 2005 to 2006.
He was also a Vice President of Non-Clinical Research at DURECT Corp.
in 2005.
From 2006 to 2009, he worked as a Vice President of Preclinical Development at Alexza Pharmaceuticals, Inc. He also held the position of Vice President of Preclinical Drug Safety at Limerick BioPharma, Inc. Dr. Taylor received a graduate and doctorate degree from Utah State University.
Former positions of Michael J. Taylor
| Companies | Position | End |
|---|---|---|
| ALEXZA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2009-01-31 |
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Corporate Officer/Principal | 2006-07-31 |
| DURECT | Corporate Officer/Principal | 2004-12-31 |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
Training of Michael J. Taylor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
DURECT Corp.
DURECT Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for pain and chronic diseases | Health Technology |
Alexza Pharmaceuticals, Inc.
Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the acute treatment of central nervous system conditions | Health Technology |
Utah State University
Utah State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limerick BioPharma, Inc.
Limerick BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
- Stock Market
- Insiders
- Michael J. Taylor
















